Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jacob Mills

Interventional Pain Medicine Mountain Home, TN Medical Doctor

NPI 1457596702 CMS profile 1492829

Corner Of Lamont & Veterans Way, Mountain Home, TN 37684

Open in the dashboard

General payments

$24,272

249 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jacob Mills of Mountain Home, TN is reported in the CMS Open Payments database as having received $24,272 across 249 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,711 48
2024 General $6,629 71
2023 General $2,095 31
2022 General $5,278 41
2021 General $676 16
2020 General $92 2
2019 General $4,793 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jacob Mills
  • Interventional Pain Medicine median
  • Middle half of Interventional Pain Medicine
  • National median

In program year 2025, general payments to Jacob Mills were reported at $4,711. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.

Show as a table
Year Jacob Mills Interventional Pain Medicine median Middle half National median
2019 $4,793 $684 $216–$2,079 $163
2020 $92 $382 $122–$1,109 $114
2021 $676 $552 $167–$1,554 $132
2022 $5,278 $605 $187–$1,924 $149
2023 $2,095 $671 $195–$1,915 $160
2024 $6,629 $684 $206–$1,837 $164
2025 $4,711 $657 $184–$1,753 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $8,739 108 payments
  2. MML US, Inc. $4,351 24 payments
  3. Nevro Corp. $2,840 24 payments
  4. Spinal Simplicity, LLC $2,677 28 payments
  5. Vertiflex, Inc. $1,661 6 payments
  6. Abbott Laboratories $1,083 13 payments
  7. SPR Therapeutics, Inc $989 5 payments
  8. Medtronic USA, Inc. $522 13 payments
  9. Nalu Medical, Inc. $348 10 payments
  10. Collegium Pharmaceutical, Inc. $234 3 payments
  11. Other $828 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $14,274 210 payments
  2. Travel and Lodging $9,998 39 payments
Products named General payments · program years 2019–2025
  1. INTELLIS ADAPTIVESTIM $7,353 90 payments
  2. ReActiv8 $4,351 24 payments
  3. HA MINUTEMAN G3-R $2,677 28 payments
  4. Senza Spinal Cord Stimulation System $2,351 17 payments
  5. Superion ISS $1,661 6 payments
  6. PROCLAIM $1,083 13 payments
  7. SPRINT PNS System $989 5 payments
  8. INCEPTIV $669 7 payments
  9. Nalu Neurostimulation System $348 10 payments
  10. INTELLIS $333 7 payments
  11. Other $2,325 43 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

249 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Pain Medicine in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record